Using KIF1A-associated neurological disorder (KAND) as a model system, single-molecule biophysical phenotyping of 91 pathogenic variants with longitudinal clinical characterization of 343 patients offers a prognostic tool and a stratification strategy for clinical trials.
These prediction models demonstrate the feasibility of early prognostication in KCNQ2-RD and support future prospective external validation and enable more accurate individualised counselling by integrating clinical and genetic information readily available at time of genetic diagnosis.
E. Van Boxstael, C. Millevert, M. Hairabedian et al.· medRxiv· 0 citations
Amyotrophic Lateral Sclerosis (ALS) is a phenotypically diverse neurodegenerative disorder characterized by the degeneration of motor neurons, ultimately resulting in loss of motor function. Currently, patients are classified based on clinical factors which does not fully capture the heterogeneity. Using the Olink Expl...
I. Aksoylu, L. Azizi, L. OÌijerstedt et al.· medRxiv· 0 citations
A hypothesis-generating load-capacity framework comprising regulatory load, network capacity, developmental buffering and regulatory network instability is proposed, and the Instability Twin is described as a prospective architecture composed of independently testable patient-specific sub-models rather than an existing...
H. Goel, T. Dudding-Byth, B. Kamien· Genes· 0 citations
Objectives Genotype–phenotype studies in rare epilepsies typically relate a pathogenic DNA sequence change to clinical outcome, without considering the broader molecular context of a given variant. Here we ask whether clinical heterogeneity in SCN8A-related disorders (SCN8A-RD) is patterned along molecular dimensions t...
Joshua B. Hack, Joseph C. Watkins, Michael F. Hammer· bioRxiv· 0 citations
“hemiconvulsion-hemiplegia-epilepsy syndrome” is identified as a distinct feature and potential prognostic indicator for middle domain variants in DNM1L variants, which are predominantly missense, with the middle domain as a hotspot.
Han Xu, Chao-Long Xu, Ying Zou et al.· Frontiers in Neurology· 0 citations
Parkinson’s disease (PD) is a heterogeneous neurodegenerative disorder with variable long-term outcomes. Blood-based biomarkers for prognostic prediction remain underdeveloped. We aimed to develop a peripheral blood transcriptomic signature for predicting long-term complications in PD using unsupervised data-driven met...